BIOMARIN PHARMACEUTICAL INC ($BMRN)
Filing Information
| Accession Number | 0001628280-26-019266 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 18, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
66,379
Total Value
$91,305.45
P&L
+inf% (+$3,504,917.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief R&D Officer | Common Stock | โ | Mar 16, 2026 | Grant/Award | 19,150 | $0.00 | $0.00 | 56,728 | Direct | โ | View Details | |
EVP, Chief R&D Officer | Common Stock | โ | Mar 17, 2026 | Tax Withholding | 1,629 | $56.05 | $91,305.45 | 55,099 | Direct | โ | View Details | |
EVP, Chief R&D Officer | Stock Option (Right to Buy Common Stock) | Derivative | Mar 16, 2026 | Grant/Award | 45,600 | $0.00 | $0.00 | 45,600 | Direct | โ | View Details |